Long-term treatment with the fatty acid oxidation inhibitor trimetazidine improves systolic function but does not affect left ventricular dilation in heart failure

✍ Scribed by Eric E. Morgan; Tracy A. McElfresh; Margaret P. Chandler; Martin E. Young; Brian D. Hoit; William C. Stanley

• Book ID: 119212443
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 51 KB
• Volume: 10
• Category: Article
• ISSN: 1532-8414
• DOI: 10.1016/j.cardfail.2004.06.257